Work

Impact of Recent Findings on Study Design of Future Autism Clinical Trials

Year: 2004

Type: article

Source: CNS Spectrums

DOI: 10.1017/s109285290000835x

Authors: Eric Hollander, Ann Phillips, Bryan H. King, Donald Guthrie, Michael G. Aman, Paul Law, Thomas Owley, Ricki Robinson

Institutions: Icahn School of Medicine at Mount Sinai, Dartmouth College, University of California, Los Angeles, Ohio University, Johns Hopkins University, University of Chicago, University of Southern California

Language: English

Topic: Autism Spectrum Disorder Research

Subfield: Cognitive Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Food and Drug Administration, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke

Awards: A Pharmacogenetic Study of Escitalopram in Autism, G1412749305, Divalproex Sodium/Placebo In Child/Adolesent Autism, G3142771170, Greater New York Autism Research Center of Excellence, G5890587754, G6315222327

OpenAlex ID: W87600889

FWCI: 1.511

Cites: 18

Cited by: 21

Related to: 10